Comprehensive Analysis of Respiratory Events Using Smartphone Systems

NCT ID: NCT03457428

Last Updated: 2019-02-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

83 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-10-31

Study Completion Date

2018-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Earlier studies suggest that acoustical analysis of snoring sounds can identify obstructive sleep apnea (OSA). The goal of the current study is to refine and validate algorithms for OSA diagnosis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Obstructive sleep apnea (OSA) is a form of sleep-disordered breathing (SDB) where cessation of breathing occurs during sleep in 9% of middle-aged women and 25% or middle-aged men. Major health issues and risks have been linked to untreated sleep apnea, including drug-resistant hypertension, obesity, congestive heart failure and diabetes.

Patient awareness of this condition is growing, but obtaining adequate data has continuing barriers. The gold standard for sleep testing is the overnight clinical polysomnogram (PSG) where over 20 sensors are attached to a patient and vital signs are monitored and recorded over the course of a 6-8 hour sleep test.

This is a prospective clinical performance study to compare the ability of proprietary algorithms that analyze sleep recordings from smartphones, with FDA cleared Level III home sleep testing (HST) devices, to identify patients with obstructive sleep apnea (OSA).

Consecutive patients referred for home sleep testing (HST) for possible OSA will be offered participation. Participants who provide informed consent will fill out a questionnaire and then proceed with HST in their home. During HST, additional sound recordings will be made with either:

1. Android type smartphone with a recording application (app). The phone will be placed on a table 50-100 cm (20-40 inches) from patient's mouth.

or
2. IPhone type smartphone with a recording application (app). Phone will be placed on a table 50-100 cm (20-40 inches) from patient's mouth

The sound recordings obtained via smartphones will be analyzed electronically for OSA by the proprietary algorithms. This will be performed by engineers at Resonea, Inc., the study sponsor, who will be blinded to the results obtained by the Level III HST device

HST will be performed using a type III home sleep monitor that has been cleared by the FDA and validated to assist in the diagnosis of OSA. HST results will be interpreted according to the standards established for the device being utilized. HST tests will be interpreted by sleep medicine physicians at the study sites who will be blinded to the assessment from the proprietary algorithms.

The independently determined results of HST and proprietary algorithms analysis will then be compared.

The results of the proprietary algorithm testing will not be known to those providing HST and the proprietary algorithm analysis will not be utilized in the clinical management of study participants

The primary objectives are: (a) to demonstrate that obtaining recordings in home setting for use with the proprietary sound analysis software is feasible and safe; and (b) to compare the results of the proprietary algorithm score with HST for the diagnosis of OSA.

The secondary objectives are: (a) to compare the recorded sound data against various scoring metrics from the HST; and (b) to demonstrate that use of the sound analysis software on smartphones is feasible for patients in the home sleep setting; and (c) to use the proprietary software to identify sleep disordered breathing beyond OSA, including central sleep apnea, snoring and other conditions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obstructive Sleep Apnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* referred for polysomnography (PSG) because of possible obstructive sleep apnea (OSA)
* owns/possesses a smartphone for use during the study. Must be:

* Android models running Android OS Samsung Galaxy 5 or later
* iPhone models running iOS 6 or later

Exclusion Criteria

* previous PSG or home sleep testing (HST) confirmation of OSA
* prior surgery for snoring or OSA
* medical contraindication of HST, as applicable
* congnitive impairment that might interfere with obtaining informed consent, or completing Clinical Questionnaire
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Resonea, Inc

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jonathan Freudman

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jon Freudman, MD

Role: PRINCIPAL_INVESTIGATOR

Resonea, Inc

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Peninsula Sleep Center

Burlingame, California, United States

Site Status

Santa Monica Clinical Trials

Santa Monica, California, United States

Site Status

Blue Sleep

New York, New York, United States

Site Status

Sounds Sleep Health

Kirkland, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Karunajeewa AS, Abeyratne UR, Hukins C. Multi-feature snore sound analysis in obstructive sleep apnea-hypopnea syndrome. Physiol Meas. 2011 Jan;32(1):83-97. doi: 10.1088/0967-3334/32/1/006. Epub 2010 Nov 30.

Reference Type BACKGROUND
PMID: 21119221 (View on PubMed)

Abeyratne UR, de Silva S, Hukins C, Duce B. Obstructive sleep apnea screening by integrating snore feature classes. Physiol Meas. 2013 Feb;34(2):99-121. doi: 10.1088/0967-3334/34/2/99. Epub 2013 Jan 23.

Reference Type BACKGROUND
PMID: 23343563 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CARESS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Precision Sleep Medicine
NCT06903481 COMPLETED